







































































Information M55. Information Methods for Predicting Risk andOutcome of Stroke
Linda Liang, Rita Krishnamurthi, Nikola Kasabov, Valery Feigin
Stroke is a major cause of disability and mortality
in most economically developed countries. It is the
second CE0 leading cause of death worldwide (after
cancer and heart disease) [55.1, 2] and a major
cause of disability in adults in developed countries
[55.3]. Personalized modeling is an emerging
effective computational approach, which has
been applied to various disciplines, such as in
personalized drug design, ecology, business, and
crime prevention; it has recently become more
prominent in biomedical applications. Biomedical
data on stroke risk factors and prognostic data
are available in a large volume, but the data are
complex and often difficult to apply to a specific
person. Individualizing stroke risk prediction and
prognosis will allow patients to focus on risk factors
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specific to them, thereby reducing their
stroke risk and managing stroke outcomes
more effectively. This chapter reviews various
methods–conventional statistical methods and
computational intelligent modeling methods for
predicting risk and outcome of stroke.
55.1 Introduction
The TS1 TS2 human brain is a control center, an intricate
master computer that controls and integrates various or-
gan systems of the body. The nerve cells of the brain
are connected with other cells in every part of the body.
They deliver messages from the brain to tell the organ
systems and the brain itself how to function, commu-
nicate, form memories, or make decisions. They also
send messages back to the brain, telling it what is hap-
pening throughout the body. The brain is a complex
system which evolves its functions and structures dur-
ing its lifetime [55.4]. In the brain, there are complex
interactions between genes and neuronal functions.
However, abnormalities in some of these inter-
actions might cause brain diseases, such as brain
cancer, Parkinson’s disease, and Alzheimer’s disease,
etc. Stroke is a prevalent brain disease and has become
a major public health challenge and concern in New
Zealand, as well as globally. As proposed by Tobias
et al. [55.5], in New Zealand, over 7000 people each
year will experience a stroke event, and at least three-
quarters of this population will die or be dependent on
others for health care 1 year after stroke.
Until now, many intelligent systems have been de-
veloped with the purpose of improving health care and
providing better health care facilities at a reduced cost.
However, a review of the literature on stroke occur-
rence and outcome shows that traditional predictive
models using standard population statistics can only
apply to a group of people and are unable to pre-
dict the degree of risk occurrence or disability level
for either an individual person at risk of stroke or
a stroke survivor. These conventional statistical meth-
ods of prediction employ only the most significant
predictive variables so that less statistically significant
personal information that may be clinically significant
for a particular person but not for a group of people is
certainly lost [55.6]. For that reason, the concept of per-
sonalized modeling may indeed be an ideal approach
CE
0 Should "second" read "third"?
TS1 Please provide the index entries.
TS2 The name “Introduction” is not allowed for the first section. Please supply a different name.












































































worth exploring and integrating into the medical system
for diagnosis, prediction, and management. Personal-
ized modeling is an emerging effective approach for
knowledge discovery in biomedical applications. The
principle of this computational intelligent approach is
to create a personalized diagnostic or prediction model
for an individual person based on his/her nearest neigh-
bors of predictive variables that are pertinent to that
person.
The objectives of this chapter are to provide a brief
introduction to stroke and then review various in-
formation methods, including conventional statistical
methods and computational intelligent modeling meth-
ods for predicting risk and outcome of stroke.
55.2 Literature Review
55.2.1 Stroke
What Is a Stroke?
The World Health Organization (WHO) defines stroke
as [55.7]:
rapidly developing clinical signs of focal or global
disturbance of cerebral function lasting more than
24 hours (unless interrupted by surgery or death)
with no apparent cause other than of vascular
origin.
It is generally accepted that the lifetime risk of stroke
occurrence is 1 in 6, at least as high as the risk for
developing Alzheimer’s disease [55.8].
Stroke has also a large physical, psychological and
financial impact on patients/families, the health care
system, and society [55.9,10]. Lifetime costs per stroke
patient range from US$59.8K to US$230K [55.10]. The
majority (about 75%) of cases of stroke occur in peo-
ple over the age of 65 years [55.11, 12], and about
one third of patients die of stroke within a year of
onset [55.13, 14]. Over half of the survivors remain de-
pendent on others for everyday activities, often with
significant adverse effects on caregivers [55.15].
Their family members are also affected due to the
suffering of their loved ones as well as by the burden of
caring for them, uncertain about future plans and anx-
ious about increased financial burdens for the patient’s
treatment.
What Are the Risk Factors?
There are about 200 factors that can increase the risk of
a stroke but the most important ones are:
• Elevated blood pressure• Smoking• Diabetes mellitus• Increasing age• Overweight (especially abdominal obesity)• High blood cholesterol level
• Poor, unbalanced diet lacking fruit and vegetables• Sedentary lifestyle• Heart rhythm problems such as atrial fibrillation• History of heart disease.
What Are the Symptoms?
The signs and symptoms of a stroke differ and depend
on the area of the brain affected and the amount of brain
tissue damaged. Small strokes may not cause any sig-
nificant focal neurological symptoms (so-called silent
strokes). However, when accumulated, they may lead to
clinically significant consequences, such as vascular de-
mentia. In general, stroke in the left side of the brain has
clinical symptoms on the right side of the body, whereas
the left side of the body is affected by a stroke in the
right side of the brain.
According to the US National Institute of Neuro-
logical Disorders and Stroke (NINDS), the common
symptoms of stroke generally come suddenly and may
include:
• Sudden loss of consciousness: the victim may be-
come stuporous or hard to arouse.• Sudden loss of vision: difficulty with seeing in one
or both eyes, such as blurred vision.• Sudden headache: sudden onset severe headache
that may be accompanied by vomiting or dizziness
(loss of balance).• Sudden trouble with muscle movements: difficulty
with walking, moving the arm or leg on one side of
body, carrying or picking up objects.• Sudden trouble with speaking and understand-
ing: may have problems with thinking or forming
speech, such as when speaking, the words sound
fine but do not make sense.
How Does Stroke Happen?
Stroke is a heterogeneous disorder that consists of two
major pathological types (ischemic and hemorrhagic),




























































































Fig. 55.1 (a) Ischemic stroke occurs when a blood vessel in the brain becomes blocked [55.16]. (b) Intracerebral hemor-
rhage occurs when blood vessels within the brain become damaged and burst within the brain [55.16]. (c) Subarachnoid
hemorrhage occurs when a cerebral aneurysm ruptures; blood will fill the space surrounding the brain [55.16]
causes and outcomes. The two major types of stroke are
described below (Fig. 55.1a–c).
Ischemic Stroke. Ischemic stroke is the most common
type of stroke, accounting for almost 85% of all stroke
cases. It occurs when there is a blood clot in the blood
vessel of the brain that reduces or blocks the blood sup-
ply coming from the heart to the brain. As there is no
nutrient/energy storage in the brain, it needs a constant
supply of nutrients from the blood. The blood carries
sugar and oxygen to the brain and takes away cellular
waste and carbon dioxide. If an artery is blocked, the
brain cells cannot receive the required level of oxygen
and glucose needed, thus the affected cells begin to shut
down. If there is no blood supply for as little as 7 s, the
affected brain cells may die.
Based on different mechanisms of stroke, ischemic
stroke consists of at least 4 subtypes: cardioembolic
stroke, ischemic stroke due to large artery disease (such
as atherosclerosis), ischemic stroke due to small artery
disease (such as hypertension, intracranial arteritis), and
ischemic stroke due to hematological disorders and
other rare conditions.
Hemorrhagic Stroke. Hemorrhagic stroke accounts for
up to 15% of all stroke cases. It often happens when
an artery bursts and bleeds into the brain (intracerebral
hemorrhage) or around the brain (subarachnoid hemor-
rhage).
Intracerebral Hemorrhage. Intracerebral hemorrhage
is a type of stroke caused by the breaking of a dis-
eased blood vessel in the brain, leading the blood to leak
into the brain tissue. This may lead to direct (destroy-
ing brain cells) or indirect damage of the affected brain
cells due to a sudden build-up in the intracranial pres-
sure, each of which may lead to unconsciousness, lost
neurological function, or even death. Intracerebral hem-
orrhage may be caused by different mechanisms (e.g.,
elevated blood pressure, amyloid angiopathy) in differ-
ent parts of the brain (e.g., supratential, infratentirial CE3
hemorrhage), each of which carries a different progno-
sis and requires different management strategies.
Subarachnoid Hemorrhage. Subarachnoid hemorrhage
is the result of a blood vessel bursting in the area be-
tween the brain and the thin tissues that surround the
brain. This area is called the subarachnoid space, which
is the area outside of the brain tissue. Typical symp-
toms of a patient with subarachnoid hemorrhage include
loss of consciousness, vomiting, severe headache or
neck pain, and neck stiffness. Subarachnoid hemor-
rhage most often results from a rupture of an intracranial
aneurysm but it may also be caused by a rupture of the
brain artery due to other causes (so-called nonaneurys-
mal subarachnoid hemorrhage). The management of
aneurysmal subarachnoid hemorrhage is very much
different from the management of nonaneurysmal sub-
arachnoid hemorrhage.
CE3 Should these read: supratentorial, infratentorial?













































































55.2.2 Information Methods for Predicting
Risk and Outcome of Stroke
To date, a number of technologies have been adopted
to predict stroke occurrence and outcomes. These tech-
nologies can be divided into two major categories:
conventional statistical methods and computational in-
telligent machine learning methods.
Conventional Statistical Methods
Currently conventional statistical methods are more
widely used and commonly applied for stroke predic-
tion data analysis. For example, descriptive statistics
(e.g., frequency statistics) has been used to calculate the
frequency of strokes in the general population, across
gender, and ethnic groups etc. [55.17]; the correlation
method (e.g., Spearman rank correlation) was utilized
to compute the correlation between two different scales,
such as the Barthel index and SF-36 [55.18]; logistic re-
gression was applied to analyze the factors associated
with the SF-36 subscales in order to discover which of
these variables best discriminate between patients with
low and high scores on the SF-36 subscales [55.19];
and one-way of variance and χ2 (chi square) test have
been adopted to assess the differences between different
stroke outcomes [55.20].
However, conventional statistical methods have lim-
itations in efficiency and prediction accuracy compared
to machine learning methods. Khosla and his col-
leagues [55.21] present an integrated machine learning
approach to compare the Cox proportional hazards
model (one of the most commonly used conventional
statistical methods in medical research) on the Car-
diovascular Health Study (CHS) dataset for stroke
risk prediction. Their research demonstrated that ma-
chine learning methods significantly outperform the
Cox model in terms of stroke risk estimation.
Machine Learning Methods
In [55.22]:
Machine learning is the process of discovering and
interpreting meaningful information, such as new
correlations, patterns and trends by sifting through
large amounts of data stored in repositories, using
pattern recognition technologies as well as statisti-
cal and mathematical technique.
In other worlds, machine learning is a process of us-
ing different analysis techniques to observe previously
unknown, potentially meaningful information, and dis-
cover strong patterns and relationships from a large
dataset that can be applied most accurately to a partic-
ular person. Kasabov [55.23] classified computational
models into three categories (e.g., global, local, and
personalized), which have being widely used in the ar-
eas of data analysis and decision support in general,
and in the areas of medicine and bioinformatics in
particular. A review study shows that the personalized
modeling approach generally outperforms the conven-
tional statistical methods for prediction or classification
of conditions.
Personalized Modeling. The concept of personal-
ized modeling is one type of local modeling that
is created for every single new input vector of the
problem space based on its nearest neighbors using
the transductive reasoning approach [55.23]. The ba-
sic philosophy behind this approach when applied to
medicine is that every person is different from oth-
ers, thus he/she needs and deserves a personalized
model and treatment that best predicts possible out-
comes for this person. This way of reasoning is much
closer to a way of clinical decision making that is used
by clinicians in their everyday practice as opposed to
a group-based approach utilized by conventional statis-
tical methods.
Personalized modeling is a novel and effective
method that has been applied for evaluating and dealing
with a variety of modeling problems. For instance, in
the field of personalized health care, the knowledge un-
covered by this approach has significantly contributed
to prediction, diagnosis, and therapy for individual
patients’ diseases. In the articles by Ginsburg and Mc-
Carthy [55.24] and TEMU [55.25], it is mentioned that
providing a personalized therapy for an individual pa-
tient during the diagnosis time frame has proved to be
very efficient and helpful.
Nowadays, the concept of personalized medicine is
becoming a leading trend in medicine, health care, and
life science. As presented by Lesko [55.26], from US
Food and Drug Administration
Personalized medicine can be viewed. . . as a com-
prehensive, prospective approach to preventing,
diagnosing, treating, and monitoring disease in
ways that achieve optimal individual healthcare de-
cisions.
As stated by the Personalized Medicine Coali-
tion [55.27], traditional medicine is primarily based on
the visible symptoms of the disease, but recently doc-
tors have been able to integrate an individual patient’s













































































cer (e.g., breast cancer, brain cancer, and liver cancer,
etc.) to make a decision about treatment. Furthermore,
according to Ginsburg and McCarthy [55.24], the objec-
tive of personalized medicine is to determine a patient’s
disease at the molecular level, so the right therapies can
be applied to the right people at the right time. The
personalized medicine approach is being increasingly
used to accommodate the individual patient’s molecu-
lar/genetic profile.
Currently, there are several methods of personalized
modeling, which are outlined below.
K Nearest Neighbor (KNN). The simplest method of per-
sonalized modeling was originally proposed by Fix and
Hodges in 1951 [55.28]. KNN is a supervised learning
algorithm that has been successfully used for classify-
ing sets of samples based on nearest training samples in
a multi-dimensional feature space.
The basic idea behind the KNN algorithm is as fol-
lows:
• Firstly, a set of pair features (e.g., (x1, y1), . . . ,
(xn, yn)) are defined to specify each data point, and
each of those data points are identified by the class
labels C = {c1, . . . , cn}.• Secondly, a distance measure is chosen (e.g., Eu-
clidean distance or Manhattan distance) to measure
the similarity of those data points based on all their
features.• Finally, the k-nearest neighbors are found for a tar-
get data point by analyzing similarity and using the
majority voting rule to determine which class the
target data point belongs to.
Weighted Nearest Neighbor (WKNN). This is designed
based on the transductive reasoning approach, which
has been widely used to evaluate the output of a model
focusing on solely an individual point of a problem
space using information related to this point [55.29].
In the WKNN algorithm, each single vector requires
a local model that is able to best fit each new input
vector rather than a global model, thus each new input
vector can be matched to an individual model without
taking any specific information about existing vectors
into account.
In contrast to the KNN algorithm, the basic idea be-
hind the WKNN algorithm is that the output of a new
input vector is calculated not only depending upon its
k-nearest neighbor vectors, but also upon the distance
between the existing vectors and the new input vector,
which is represented as a weight vector w.
Weighted Distance and Weighted Variables K Near-
est Neighbor (WWKNN). This is a novel personalized
modeling algorithm, which was proposed by Kasabov
in 2007. The basic idea behind this algorithm is as fol-
lows: the output of each new input vector is measured
not only depending upon its k-nearest neighbors, but
also upon the distance between the existing vectors and
the new input vectors, and also the power of each vector
which is weighted according to its importance within
the subspace (local space) to which the new input vec-
tor belongs. We start with the assumption that all the
variables from a data set are used and the distance of
vectors is calculated in a V-dimensional space with all
input variables having the same impact on the output
variables. However, the different variables may vary in
importance when classifying vectors if these variables
are ranked by their discriminative power in classifying
vectors over the entire V-dimensional Euclidean space.
As a result, it can be seen that variables may have
a different ranking when we measure the discrimina-
tive power of the same variables for a subspace of the
problem space. The output of each new input vector can
be calculated by using this type of ranking within the
neighborhood of k-nearest neighbor vectors.
Evolving Spiking Neural Networks (eSNN). The brain
is the center of the nervous system, it is an extremely
complex organ. The cerebral cortex of the human brain
contains roughly 15–33 billion neurons, depending on
gender and age, linked with up to 10 000 synaptic con-
nections each.
A typical neuron in the human brain is sketched in
Fig. 55.2. A typical neuron can be divided into three
functionally distinct parts, called dendrites, soma, and
axon. Generally speaking, the dendrites play the role of
the input devices that collect signals from other neurons
and transmits them to the soma. Soma is the main part
of the neuron containing the genetic information: if the
total input exceeds a certain threshold, then an output
signal is generated. The output signal is taken over by
the output devices, the axons, which deliver the signal
to other neurons or other parts of the body. The junction
between two neurons is called a synapse. It is used to
transfer signals between two neurons.
The remarkable information processing capabilities
of the brain have inspired numerous mathematical ab-
stractions of biological neurons. A neural network (NN)
known as an artificial neural network (ANN) is defined
as a hardware or software computational model that
is inspired by the biological nervous systems, such as
the brain, and processes CE4 information. Many ANN
CE4 Please check that this is the intended meaning.
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Fig. 55.2 Schematic drawing of
a typical neuron [55.31]
models have been successfully developed and applied
across many disciplines, including classification, time
series prediction, pattern recognition, and so on [55.30].
However, current ANN models do not provide good
performance when applied to complex stochastic and
dynamic processes such as modeling brain diseases. For
this reason, new ANN models should be developed in
order to become more accurate and efficient in knowl-
edge discovery and information processing.
Maass [55.32] classifies past and current neural
network models into three generations. Spiking neu-
ral networks (SNN) is the third generation of neural
network models, which is a complex and biologically
plausible connectionist model. In biological systems
neurons are connected at synapses, and signals trans-
fer information from one neuron to another. Quite
a few models of SNN have been developed so far:
Hodgkin–Huxley’s model [55.33]; Spike response mod-
els [55.34–36]; integrate-and-fire models [55.35, 37];
Izhikevich models [55.38–40], etc.
SNN has been increasingly applied in the field
of science and engineering as in other disciplines to
solve complicated prediction and classification prob-
lems, such as speech recognition [55.41], audio and
video analysis [55.42, 43], and financial forecasting
[55.44]. In recent years, SNN has become a powerful
computational tool that has been widely adopted for di-
agnosing and monitoring the prognosis of a disease, as
evidenced by over 500 published papers each year fea-
turing neural network applications in medicine [55.45].
In medical practice, SNN has been successfully used
for diagnosing breast cancer [55.46], making progno-
sis for patients with congestive heart failure [55.47],
and predicting the risk of death for lung cancer pa-
tients [55.48].
More recently, spiking neural networks have been
successfully used for the prediction of functional
outcome associated with clinical variables that are
associated with rehabilitation in stroke [55.6]; early di-
agnosis of ischemic stroke [55.49] and classifying the
gait patterns of post-stroke patients into homogenous
groups [55.50].
Evolving SNN (eSNN), which is an SNN approach,
was first proposed by Wysoski et al. in 2006 [55.51]. It
consists a set of SNN that evolve their structure through
incremental and fast one-pass learning from data.
Space and time can be viewed as the important as-
pects of all real-world phenomena. Spatio-temporal data
(STD) contains information relating space and time.
According to Fayyad and Grinstein [55.52], nowadays,
approximately 80% of the available datasets have spa-
tial components and are often related to some temporal
aspects. Examples of such data are environmental, au-
dio/visual, medical, and brain signals. So far, most
available stroke data are STD, thus a great challenge is
how to process these complex STD.
In general, classical statistical and computational
techniques are insufficient when they are applied to
spatio-temporal datasets for the following reasons:
• Spatio-temporal datasets are embedded into contin-
uous space, whereas the classical datasets are often
discrete.• The patterns in these datasets are often local,
but classical techniques normally focus on global
patterns.• They model either space and time separately, or
mix both components in a simple way, failing CE5 to
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eSNN is considered an emerging computational
technique for the analysis of spatio-temporal datasets.
As proposed by Kasabov [55.30], the development of
a novel integrated evolving personalized modeling sys-
tems by utilizing novel technology such as evolving
spiking neural networks (eSNN) might facilitate more
precise decision-making to ensure patients receive opti-
mal prognosis and treatment.
55.3 Conclusion
The human brain is a complex network of inter-
connected cells (neural networks) that develops its
functionalities and structures during the lifetime of
a person. There are complex interactions between
genes, the environment, and neuronal function within
the brain. However, some of these interactions might
become abnormal and cause brain diseases.
Stroke is a prevalent brain disease and has become
a major public health concern in New Zealand, as in
many other countries worldwide. A large volume of
biomedical data on stroke risk factors and prognosis is
available, but the interpretation of this data is complex
and challenging. An increasing number of studies have
attempted to explore these complex data, but most of
these studies applied conventional statistical methods.
Literature reviews show that the traditional predictive
models using conventional statistical methods can only
apply to a group of people and are unable to predict the
degree of risk occurrence or disability level for either an
individual person at risk of stroke or a stroke survivor.
Therefore, there is a growing need for utilizing com-
putational models to study this data, especially applied
to estimating personalized risk to better understand the
pathophysiology in individual and specific groups of
stroke, and to achieve improved and reliable risk pre-
diction for individuals.
Personalized modeling was recently proposed as
a novel method for knowledge discovery in biomed-
ical applications. The basic philosophy behind this
computational intelligent approach when applied to
medicine is that every person is different from others,
thus he/she needs and deserves a personalized model
and treatment that best predicts possible outcomes for
this person. The principle of this approach is to cre-
ate a personalized diagnostic or prediction model for
an individual person based on his/her nearest neigh-
bors of predictive variables that are pertinent for that
person. For instance, employing eSNN might result
in reducing the time, cost, medical error, and mortal-
ity rate. The concept of personalized modeling can be
viewed as an ideal approach well worth exploring and
integrating into the medical system for diagnosis, pre-
diction, and prescription of various diseases, including
stroke.
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